247 related articles for article (PubMed ID: 15619029)
1. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
Kanou T; Uozumi J; Soejima K; Tokuda Y; Masaki Z
Clin Exp Nephrol; 2004 Dec; 8(4):310-5. PubMed ID: 15619029
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gluconeogenesis and p-aminohipuric acid accumulation in rat renal cortical slices by ionic and nonionic contrast media.
Nakamura M; Uozumi J; Soejima K; Kanou T; Tokuda N; Naito S
Clin Exp Nephrol; 2003 Jun; 7(2):98-103. PubMed ID: 14586727
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes.
Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cytotoxicities of platinum compounds.
Goodisman J; Hagrman D; Tacka KA; Souid AK
Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
[TBL] [Abstract][Full Text] [Related]
5. Impairment of the renal p-aminohippurate transport induced by 6-hydroxydopamine.
Cojocel C; Thomson MS
J Pharm Pharmacol; 2003 May; 55(5):669-74. PubMed ID: 12831510
[TBL] [Abstract][Full Text] [Related]
6. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
Mandal R; Kalke R; Li XF
Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
[TBL] [Abstract][Full Text] [Related]
7. In vitro histoculture drug response assay and in vivo blood chemistry of a novel Pt(IV) compound, K104.
Kwon YE; Park JY; Kim WK
Anticancer Res; 2007; 27(1A):321-6. PubMed ID: 17352249
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
Haschke M; Vitins T; Lüde S; Todesco L; Novakova K; Herrmann R; Krähenbühl S
Nephrol Dial Transplant; 2010 Feb; 25(2):426-33. PubMed ID: 19736245
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Holzer AK; Manorek GH; Howell SB
Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
[TBL] [Abstract][Full Text] [Related]
12. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
[TBL] [Abstract][Full Text] [Related]
13. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
14. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
Leibbrandt ME; Wolfgang GH
Toxicol Appl Pharmacol; 1995 Jun; 132(2):245-52. PubMed ID: 7785052
[TBL] [Abstract][Full Text] [Related]
15. The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin.
Oprea A; Bazzazi H; Kangarloo B; Wolff JE
Anticancer Res; 2001; 21(2A):1225-9. PubMed ID: 11396168
[TBL] [Abstract][Full Text] [Related]
16. Kinetic study on the reactions of platinum drugs with glutathione.
Hagrman D; Goodisman J; Souid AK
J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity.
Bouthillier L; Charbonneau M; Brodeur J
Toxicol Appl Pharmacol; 1996 Jul; 139(1):177-85. PubMed ID: 8685901
[TBL] [Abstract][Full Text] [Related]
19. Tiopronin protects against the nephrotoxicity of cisplatin in rat renal cortical slices in vitro.
Zhang JG; Lindup WE
Toxicol Appl Pharmacol; 1996 Dec; 141(2):425-33. PubMed ID: 8975767
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between para-aminophenol toxicity in vivo and in vitro in female Sprague-Dawley rats.
Shao R; Tarloff JB
Fundam Appl Toxicol; 1996 Jun; 31(2):268-78. PubMed ID: 8789793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]